146 related articles for article (PubMed ID: 8084529)
1. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
Pinnock RD; Woodruff GN
Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area.
Werkman TR; Kruse CG; Nievelstein H; Long SK; Wadman WJ
Neuroscience; 2000; 95(2):417-23. PubMed ID: 10658621
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons.
Nalivaiko E; Michaud JC; Soubrié P; Le Fur G
Neuroscience; 1998 Oct; 86(3):799-811. PubMed ID: 9692718
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of neurotensin analogues on neurones in the rat substantia nigra, pars compacta in vitro.
Keegan KD; Woodruff GN; Pinnock RD
Eur J Pharmacol; 1994 Feb; 253(1-2):131-7. PubMed ID: 8013539
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.
Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P
Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin depolarizes substantia nigra dopamine neurones.
Pinnock RD
Brain Res; 1985 Jul; 338(1):151-4. PubMed ID: 4027584
[TBL] [Abstract][Full Text] [Related]
8. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.
Ferraro L; Tomasini MC; Fernandez M; Bebe BW; O'Connor WT; Fuxe K; Glennon JC; Tanganelli S; Antonelli T
Neuroscience; 2001; 102(1):113-20. PubMed ID: 11226674
[TBL] [Abstract][Full Text] [Related]
9. Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons.
Michaud JC; Gueudet C; Soubrié P
Neuroreport; 2000 May; 11(7):1437-41. PubMed ID: 10841353
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
Bowery B; Rothwell LA; Seabrook GR
Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
[TBL] [Abstract][Full Text] [Related]
11. Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system.
Steinberg R; Bougault I; Souilhac J; Gully D; Le Fur G; Soubrié P
Neurosci Lett; 1994 Jan; 166(1):106-8. PubMed ID: 7514773
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture.
Antonelli T; Tomasini MC; Finetti S; Giardino L; Calzà L; Fuxe K; Soubriè P; Tanganelli S; Ferraro L
J Neurosci Res; 2002 Dec; 70(6):766-73. PubMed ID: 12444598
[TBL] [Abstract][Full Text] [Related]
13. SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
Schaeffer P; Laplace MC; Bernat A; Prabonnaud V; Gully D; Lespy L; Herbert JM
J Cardiovasc Pharmacol; 1998 Apr; 31(4):545-50. PubMed ID: 9554803
[TBL] [Abstract][Full Text] [Related]
14. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
McCormick SE; Stoessl AJ
Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.
Antonelli T; Ferraro L; Fuxe K; Finetti S; Fournier J; Tanganelli S; De Mattei M; Tomasini MC
Cereb Cortex; 2004 Apr; 14(4):466-73. PubMed ID: 15028650
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S
Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors.
Matsuyama S; Higashi H; Maeda H; Greengard P; Nishi A
J Neurochem; 2002 Apr; 81(2):325-34. PubMed ID: 12064480
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
Karinch AM; Schmidt GL; Kauffman GL
Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neurotensin receptor mRNA expression by the receptor antagonist SR 48692 in the rat midbrain dopaminergic neurons.
Yamada M; Bolden-Watson C; Watson MA; Cho T; Coleman NJ; Yamada M; Richelson E
Brain Res Mol Brain Res; 1995 Nov; 33(2):343-6. PubMed ID: 8750895
[TBL] [Abstract][Full Text] [Related]
20. Ionic mechanisms of action of neurotensin in acutely dissociated neurons from the diagonal band of Broca of the rat.
Jassar BS; Harris KH; Ostashewski PM; Jhamandas JH
J Neurophysiol; 1999 Jan; 81(1):234-46. PubMed ID: 9914284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
